ArticleJournal of pain research2018

Quantitative sensory testing is feasible and is well-tolerated in patients with sickle cell disease following a vaso-occlusive episode.

Nitya Bakshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.